Latest news and press releases about Apimeds Pharmaceuticals US, Inc (APUS): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Price
| Price | $1.60 |
| Market Cap | $2M |
| Exchange | AMEX |
| Country | US |
Valuation Ratios
| Price / Book | 0.02 |
| EV / EBITDA | -0.33 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -58.98% |
| Return on Invested Capital | -15.89% |
| Return on Assets | -45.58% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: ANTX · IGC · MIRA · MLSS · MYO · NXTC · POCI
Explore sector: Healthcare · Biotechnology
More sections of APUS: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks